Inamed's Two-Year Data Insufficient For Lap-Band Approval - Panel
This article was originally published in The Gray Sheet
Executive Summary
Inamed will be able to provide FDA with three-year follow-up data in the third quarter on roughly 150 patients implanted with the firm's Lap-Band adjustable gastric banding system for obesity treatment, according to company officials.